Medical Research News

RSS

Significant number of COVID-19 positive cases asymptomatic, raising transmission concerns

There have been many instances of people testing positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who have no symptoms of the infection whatsoever. These asymptomatic patients are, however, still capable of spreading the infection without being aware of it, say experts.

31 May 2020

Ruxolitinib shows promise in severe COVID-19

An anti-inflammatory drug Ruxolitinib has shown promising results in the treatment of severe coronavirus disease COVID-19. The study titled, “Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial,” was published as a pre-proof for the Journal of Allergy and Clinical Immunology.

31 May 2020

COVID-19 mortality is significantly higher in hospitalized patients with diabetes

A new meta-analysis published on the preprint server medRxiv by the researchers from the United States and Greece reveals that the likelihood of death is 65% higher in hospitalized coronavirus disease (COVID-19) patients with diabetes when compared to non-diabetics – urging the adequate glucose control in the era of the pandemic.

31 May 2020

How susceptible are domestic animals to SARS-CoV-2?

A recent paper by Chinese researchers, published in the leading journal Science, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) does not replicate well in dogs, pigs, chickens, and ducks; however, ferrets and cats are easily infected, and cats may transmit the virus via an airborne route.

31 May 2020

Researchers assess harm reduction awareness among frequent cannabis users

Harm reduction strategies have proven effective for use of opioids, alcohol, and tobacco products.

30 May 2020

University of Freiburg receives 30 million euros for excellent research

The German Research Foundation has approved a new proposal for a collaborative research center under the leadership of the Institute for Experimental Cardiovascular Medicine at the University Heart Centre Freiburg · Bad Krozingen.

30 May 2020

Mathematical model predicts COVID-19 resurgence if physical distancing measures are relaxed

If physical distancing measures in Ontario are relaxed too much or too quickly, the province could see hospitals overwhelmed with COVID-19 patients as well as exponential growth in deaths, concludes new research involving a University of Guelph infectious disease modeller.

30 May 2020

New review analyzes appropriateness of off-pathway cancer care

Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.

30 May 2020

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.

30 May 2020

Preventing novel coronavirus from entering into a host cell

How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.

30 May 2020

Scientists track SARS-CoV-2 in wastewater

Epidemiologist David Larsen, from Syracuse University and microbiologists Hyatt Green, from the College of Environmental Science and Forestry and Frank Middleton, from Upstate Medical University are lead members of a multi-institution research project that is expected to have global application in future efforts to track and contain Sudden Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19).

30 May 2020

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases, a leading institute conducting pioneering research on infectious diseases.

30 May 2020

Assessing treatment for acute chloroquine poisoning

Research by Bangor University’s Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

30 May 2020

Study: People are drinking more alcohol, smoking more cigarettes, while exercising less and eating less healthily

New research announced today shows that despite the fact that people in the UK are optimistic and plan to be more health conscious following the pandemic (36%), we are drinking more alcohol and smoking more, while exercising less and eating less healthily.

30 May 2020

Identifying optimal vasopressor treatment for nontraumatic subarachnoid hemorrhage

Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).

30 May 2020

Study outlines the spread and causes of COVID-19

The article gives an overview of the spread of Covid-19 and outlines six causes of the crisis: the exponential infection rate, international integration, the insufficient capacity of health care systems in many countries, conflicts of competence and a lack of foresight on the part of many government agencies, the need to grapple with the economic impacts of the shutdown parallel to the health crisis, as well as weaknesses in capital markets resulting from the financial crisis of 2008.

30 May 2020

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a “tumor-tropic liposome technology” for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.

30 May 2020

Medical Research News

Significant number of COVID-19 positive cases asymptomatic, raising transmission concerns

Ruxolitinib shows promise in severe COVID-19

COVID-19 mortality is significantly higher in hospitalized patients with diabetes

How susceptible are domestic animals to SARS-CoV-2?

Researchers assess harm reduction awareness among frequent cannabis users

University of Freiburg receives 30 million euros for excellent research

Mathematical model predicts COVID-19 resurgence if physical distancing measures are relaxed

New review analyzes appropriateness of off-pathway cancer care

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Preventing novel coronavirus from entering into a host cell

Scientists track SARS-CoV-2 in wastewater

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

Assessing treatment for acute chloroquine poisoning

Study: People are drinking more alcohol, smoking more cigarettes, while exercising less and eating less healthily

Identifying optimal vasopressor treatment for nontraumatic subarachnoid hemorrhage

Study outlines the spread and causes of COVID-19

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Study solves the longstanding mystery of anesthesia

UK’s ethnic minority groups face higher risk of COVID-19

Study: First COVID-19 cases in New York City are linked to travel-related exposures

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News